findmyKOL
Clinical trialNCT03834688CompletedPhase 2Interventional

Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age

SponsorPrECOG, LLC.Enrollment33Mantle Cell Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Carle Cancer Center

    Urbana, Illinois, United States

  • Indiana University Simon Cancer Center

    Indianapolis, Indiana, United States

  • St. Joseph Mercy Hospital Cancer Care Center

    Ann Arbor, Michigan, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Washington University School of Medicine Siteman Cancer Center

    St Louis, Missouri, United States

  • Penn State Cancer Institute

    Hershey, Pennsylvania, United States

  • University of Virginia Health System

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Jan 2020
Primary completion
20 Oct 2022
Completion
26 Jul 2024
Last update posted
11 Aug 2025
Registered enrollment
33
Registry id
NCT03834688

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.